![Kenneth Kelley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Kelley
Directeur Général chez
IDBiologics, Inc.
Profil
Kenneth J. Kelley est un homme d'affaires qui a fondé IntraBiotics Pharmaceuticals, Inc. et Emergent Travel Health, Inc. et qui a été à la tête de 7 entreprises différentes. Actuellement, il occupe le poste de président de Seromyx Systems, Inc. et de président de Selva Therapeutics, Inc. M. Kelley est également membre du conseil d'administration de Halozyme Therapeutics, Inc. (ancien président), de Meissa Vaccines, Inc. et d'Actym Therapeutics, Inc. et IDBiologics, Inc. et directeur général de K2 BioVentures LLC. Au cours de sa carrière passée, Kenneth J. Kelley a été directeur de Solus Biosystems, Inc, président de Fluxion Biosciences, Inc, associé général de Latterell Venture Partners, associé d'Institutional Venture Partners, consultant de McKinsey & Co, Inc, président-directeur général d'IntraBiotics Pharmaceuticals, Inc, directeur d'Emergent Travel Health, Inc et scientifique d'Integrated Genetics, Inc. Kenneth J. Kelley a obtenu un diplôme de premier cycle à l'université de Harvard et un MBA à l'université de Stanford.
Postes actifs de Kenneth Kelley
| Sociétés | Poste | Début |
|---|---|---|
K2 BioVentures LLC | Corporate Officer/Principal | 07/07/2010 |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Directeur/Membre du Conseil | 27/03/2019 |
Actym Therapeutics, Inc.
 Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Directeur/Membre du Conseil | - |
IDBiologics, Inc.
 IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Directeur Général | 01/01/2017 |
Seromyx Systems, Inc.
 Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Président | - |
Selva Therapeutics, Inc.
 Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Président | - |
Anciens postes connus de Kenneth Kelley
| Sociétés | Poste | Fin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Président | 01/01/2015 |
Latterell Venture Partners
 Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Corporate Officer/Principal | 01/06/2004 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Kenneth Kelley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Finance |
Solus Biosystems, Inc.
 Solus Biosystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops tools for measurement of changes in protein conformation | Electronic Technology |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Commercial Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Fluxion Biosciences, Inc.
 Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Provides automated patch clamp technology and cell-based assay tools | Technology Services |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Commercial Services |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
K2 BioVentures LLC | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Health Technology |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Health Technology |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Health Technology |
IDBiologics, Inc.
IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Health Technology |
Selva Therapeutics, Inc.
Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Health Technology |
